You have 9 free searches left this month | for more free features.

Refractory Diffuse Large B-Cell Lymphoma (1)

Relapsed Diffuse Large B-Cell Lymphoma (1)

Solid Tumors (1)

Completed (1)

Terminated (1)

phase 1 (1)

phase 1/phase 2 (1)

Incyte Corporation (2)

incb053914 (2)

azacitidine (1)

i-dac (intermediate dose cytarabine) (1)

incb050465 (1)

ruxolitinib (1)

drug (2)

Industry (2)

Interventional (2)

incb053914

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Terminated

Nov 9, 2021

Completed

Nov 9, 2020